Medisyl

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

71 API Suppliers, 22 USDMF, 8 CEP/COS, 2 JDMF, 2 KDMF, 24 NDC API, 27 Listed Suppliers

DEVELOPMENTS

153 Drugs in Development

153 Drugs in Development

FINISHED DOSAGE FORMULATIONS

768 FDF Dossiers, 117 FDA Orange Book, 391 Europe, 85 Canada, 17 Australia, 35 South Africa, 123 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 356.4MG;30MG;16MG, TABLET;ORAL - 325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 325MG;50MG;40MG;30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, DELAYED RELEASE;ORAL - 325MG;40MG, TABLET, DELAYED RELEASE;ORAL - 81MG;40MG, TABLET;ORAL - 250MG;250MG;65MG, CAPSULE, EXTENDED RELEASE;ORAL - 25MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Minakem, 8 Evonik, 12 Rochem International Inc, 32 SPI Pharma, 2 Pharm-RX Chemical, 8 Boai NKY Pharmaceuticals Ltd, 9 Gangwal Healthcare, 15 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 1 Capital Farma, 12 Kirsch Pharma, 1 Panvo Organics, 2 Cerata Pharmaceuticals LLP, 22 Dr. Paul Lohmann GmbH & Co. KGaA, 4 ACG Worldwide, 15 Actylis, 2 Aeon Procare, 2 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 Ashland, 40 BASF, 1 Bioplus Life Sciences, 5 CD Formulation, 3 Clariant, 15 Corel Pharma Chem, 7 DFE Pharma, 3 Doshion Polyscience, 2 Esteem Industries, 3 Finar, 16 Gangwal Chemicals, 4 Gloria Interchem, 15 Ideal Cures, 5 Ingredion Pharma Solutions, 3 JJ Chemicals, 27 Kerry, 4 Keval Exports, 5 Kima Chemical, 6 Lonza Capsugel, 24 Microlex e.U, 1 Nanjing Bold Chemical, 4 Neelkanth MineChem, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 5 Pharmatrans-Sanaq, 11 Pluviaendo, 4 Prachin Pharmachem, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 47 Roquette, 19 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 4 The Dow Chemical Company, 2 Ulanqab Kema New Material, 2 Valens Pharmachem, 5 Vasa Pharmachem, 1 Vertellus, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

112 Fillers, Diluents & Binders, 91 Coating Systems & Additives, 58 Thickeners and Stabilizers, 56 Solubilizers, 49 Direct Compression, 48 Disintegrants & Superdisintegrants, 46 Controlled & Modified Release, 45 Taste Masking, 44 Parenteral, 42 Granulation, 35 Topical, 35 Lubricants & Glidants, 33 Film Formers & Plasticizers, 27 Chewable & Orodispersible Aids, 21 Emulsifying Agents, 19 API Stability Enhancers, 18 Co-Processed Excipients, 14 Surfactant & Foaming Agents, 9 Empty Capsules, 9 Rheology Modifiers, 4 Vegetarian Capsules, 2 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

1 Weekly News Recap #Phispers, 200 News #PharmaBuzz

GLOBAL SALES INFORMATION

19 US Medicaid Prescriptions, 33 Regulatory FDF Prices, 11 Annual Reports

MARKET PLACE

64 APIs, 43 FDF Dossiers

PATENTS & EXCLUSIVITIES

12 US Patents

12 US Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 JP, 12 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

Xls

Filters

FILTER :

filter Product Reset all filters

11 All

01 10Aspirin Cardio

02 1AspirinTM Cardio

List of Suppliers

Reset Filter

Medisyl

Medisyl

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

71 API Suppliers

22 USDMF

8 CEP/COS

2 JDMF

2 KDMF

24 NDC API

27 Listed Suppliers

DEVELOPMENTS

153 Drugs in Development

FINISHED DOSAGE FORMULATIONS

768 FDF Dossiers

117 FDA Orange Book

391 Europe

85 Canada

17 Australia

35 South Africa

123 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 356.4MG;30MG;16MG

TABLET;ORAL - 325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 325MG;50MG;40MG;30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, DELAYED RELEASE;ORAL - 325MG;40MG

TABLET, DELAYED RELEASE;ORAL - 81MG;40MG

TABLET;ORAL - 250MG;250MG;65MG

CAPSULE, EXTENDED RELEASE;ORAL - 25MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI

2 Minakem

8 Evonik

12 Rochem International Inc

32 SPI Pharma

2 Pharm-RX Chemical

8 Boai NKY Pharmaceuticals Ltd

9 Gangwal Healthcare

15 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

2 Pfanstiehl

1 Capital Farma

12 Kirsch Pharma

1 Panvo Organics

2 Cerata Pharmaceuticals LLP

22 Dr. Paul Lohmann GmbH & Co. KGaA

4 ACG Worldwide

15 Actylis

2 Aeon Procare

2 Alcedo Pharmachem

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

4 Ashland

40 BASF

1 Bioplus Life Sciences

5 CD Formulation

3 Clariant

15 Corel Pharma Chem

7 DFE Pharma

3 Doshion Polyscience

2 Esteem Industries

3 Finar

16 Gangwal Chemicals

4 Gloria Interchem

15 Ideal Cures

5 Ingredion Pharma Solutions

3 JJ Chemicals

27 Kerry

4 Keval Exports

5 Kima Chemical

6 Lonza Capsugel

24 Microlex e.U

1 Nanjing Bold Chemical

4 Neelkanth MineChem

3 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

4 Novo Excipients

5 Pharmatrans-Sanaq

TABLET;ORAL - 325MG;50MG;40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - 325MG;50MG;40MG;30MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, EXTENDED RELEASE;ORAL - 25MG;200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 325MG;50MG;40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons